TY  - GEN
AU  - Valencia, Jorge
AU  - Lazarus, Jeffrey V
AU  - Ceballos, Francisco C
AU  - Troya, Jesús
AU  - Cuevas, Guillermo
AU  - Resino, Salvador
AU  - Torres-Macho, Juan
AU  - Ryan, Pablo
PY  - 2022
DO  - 10.1111/liv.15095
UR  - http://hdl.handle.net/20.500.12105/19519
AB  - Background and aims: People who inject drugs (PWID) and other marginalized populations with high hepatitis C virus (HCV) infection rates represent a unique challenge for treatment initiation due to health, administrative and social barriers. We...
LA  - eng
PB  - Wiley
KW  - Cascade of care
KW  - Hepatitis C virus
KW  - Marginalized populations
KW  - Model of care
KW  - Point-of-care test
KW  - Hepatitis C
KW  - Hepatitis C, Chronic
KW  - Substance Abuse, Intravenous
KW  - Antiviral Agents
KW  - Hepacivirus
KW  - Humans
KW  - Point-of-Care Systems
TI  - Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care
TY  - research article
ER  -